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NEW PRENATAL SCREENING IMPROVES DETECTION OF DOWN'S SYNDROIE 
Boston, Mass.--A new combination of screenings i s now available that i s 
nearly three times more effective i n the prenatal detection of Down's syndrome 
than standard screening. The combined screening has the potential to 
dramatically increase the percentage of people who learn prenatally that they 
w i l l have an affected c h i l d . 
The Center for Human Genetics at Boston University School of Medicine 
(BUSM) is the only center i n Massachusetts and one of only a few centers i n 
the country to of f e r the combined screening. 
"This advance represents a highly s i g n i f i c a n t step i n the early detection 
of serious chromosome defects," says Aubrey Milunsky, MB.B.Ch., D.Sc, who i s 
the director of BUSM's Center f o r Human Genetics and a professor of 
pediatrics, obstetrics and gynecology, pathology and biology at BUSM. "This 
screening w i l l help women under the age of 35 who are not routinely tested for 
Down's syndrome through amniocentesis and who otherwise would not suspect that 
they would have affected children." 
Since the r i s k of Down's syndrome increases with maternal age, Milunsky 
recommends an amniocentesis--which is 100-percent accurate i n testing for 
Down's syndrome--for a l l pregnant women 34 years of age and older (the 
national recommendation i s 35 years of age and older). Because there is some 
r i s k associated with the invasive procedure, i t i s not routinely offered to 
women under the age of 35. However, 75 to 80 percent of children born with 
Down's syndrome are delivered by mothers under the age of 35. 
Currently, blood samples are drawn from a l l pregnant women at 16 weeks 
into t h e i r pregnancy to screen for the amount of alpha-fetoprotein (AFP)--a 
f e t a l protein--in t h e i r blood. This screening i s helpful i n detecting neural 
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tube defects, such as anencephaly and spina b i f i d a , high-risk pregnancies and 
multiple pregnancies. While i t may also indicate the p o s s i b i l i t y of Down's 
syndrome, the screening i s successful i n i d e n t i f y i n g only 20 percent of the 
fetuses affected w i t h Down's. 
The new combined screening for AFP and human chorionic gonadotrophin 
(HCG)--a hormone made by the placenta--is e f f e c t i v e i n detecting 50 to 60 
percent of the cases of Down's syndrome. The screenings are more e f f i c e n t i n 
combination because they measure two d i f f e r e n t functions of the fetus and 
placenta that are affected by Down's syndrome i n d i f f e r e n t ways. Down's i s 
suspected i f the screenings reveal low levels of AFP and high levels of HCG. 
I f abnormal levels are detected, an ultrasound i s used to more precisely 
pinpoint the age of the fetus. This test frequently reveals that the timing 
of the pregnancy i s inaccurate, and that, since the development of the fetus 
is actually e a r l i e r or further along than estimated, the results of the test 
are actually normal. I f the age of the fetus has been calculated correctly, 
an amniocentesis is then performed immediately to confirm or exclude the 
presence of Down's syndrome or some other serious chromosome defect. 
"This screening w i l l l e t many more parents know i f t h e i r offspring are 
affected and w i l l give them the option to continue or abort the pregnancy," 
says Milunsky. 
The Boston University School of Medicine Center for Human Genetics is a 
national academic reference center. BUSM i s located i n the South End of 
Boston between two of i t s p r i n c i p a l teaching hospitals--the University 
Hospital and Boston City Hospital. 
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